Barron's Interview Stephen Pesek
833 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons3
DESCRIPTION:

Date updated:11-01-2008

Talking With Stephen Pesek, Portfolio Manager, MFS Core Growth Fund.

symbol name last price % change open
  • +
  • AAPL
    Apple Inc.
  • $204.45
  • +1.22%
  • $202.97

His top holdings include many electronics outfits (he once ran an electronics fund for Fidelity), such as Apple (AAPL), Cisco Systems (CSCO) and IBM (IBM), all of which have suffered big price drops in the downdraft created by the credit crisis. That doesn't faze him because he invests with at least an 18-month time horizon.

People owning AAPL also tend to own: AMDCSCODELLGOOGIBMINTCMSFT

TheStreet.com Rating: B+ What is this?

  • +
  • CSCO
    Cisco Systems
  • $23.71
  • +1.32%
  • $23.53

His top holdings include many electronics outfits (he once ran an electronics fund for Fidelity), such as Apple (AAPL), Cisco Systems (CSCO) and IBM (IBM), all of which have suffered big price drops in the downdraft created by the credit crisis. That doesn't faze him because he invests with at least an 18-month time horizon.

People owning CSCO also tend to own: AAPLAMDDELLGOOGIBMINTCMSFT

TheStreet.com Rating: B- What is this?

  • +
  • IBM
    Intl Business Mac
  • $127.03
  • +0.61%
  • $126.41

His top holdings include many electronics outfits (he once ran an electronics fund for Fidelity), such as Apple (AAPL), Cisco Systems (CSCO) and IBM (IBM), all of which have suffered big price drops in the downdraft created by the credit crisis. That doesn't faze him because he invests with at least an 18-month time horizon.

People owning IBM also tend to own: AAPLAMDCSCODELLGOOGINTCMSFT

TheStreet.com Rating: A What is this?

  • +
  • ORCL
    Oracle Corporatio
  • $22.34
  • +1.36%
  • $22.08

Although Oracle, like every vendor, is under pressure to provide discounts, he thinks it can gain share in a downturn and still expand margins. "They can control their own destiny," Pesek says, because the company is dominant in database software, with a 49% share, up from 39% five years ago. What's more, it's been a very active buyer of applications businesses such as Prima-vera, Hyperion and BEA. Oracle "is a little bit controversial in terms of organic versus acquired growth, but the company has a visible margin-expansion path," Pesek explains. The Street puts Oracle's earnings per share at $1.50 in '09 and $1.68 in '10. He added to his Oracle position last spring when it was in the high teens to low 20s. Oracle was recently trading near the bottom of its 52-week range at $18.32 a share, or less than 12 times 2009 earnings projections.

People owning ORCL also tend to own: AAPLAMDCSCODELLGOOGIBMINTC

TheStreet.com Rating: B+ What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $49.28
  • -7.32%
  • $53.06

Pesek also likes Cambridge, Mass.-based Genzyme (GENZ), a biotech outfit focused on diseases stemming from enzyme disorders. "Its small nichey markets provide an opportunity to raise prices," Pesek says, noting that many of its pipeline products -- such as Myozyme, for treating often-fatal Pompe disease, which can affect muscles and the heart, and Mozibil, used to increase stem-cell counts in transplants -- benefit from orphan-drug status. Campath, for multiple sclerosis, differs because it has a potentially enormous market. The National MS Society estimates that about 200 Americans are diagnosed with this auto-immune disease every week. Overall, there are about 400,000 people in the U.S. and more than 2.5 million people worldwide suffering from MS. "Management believes they can achieve a compound annual growth rate in earnings per share of 20% from 2007-2010, and if pipeline products are successful that will be even better," Pesek says. He added to his Genzyme stake in the summer of 2007 when the stock was trading in the low to mid-60s. More recently, it's been trading at 70.20. The consensus estimate for Genzyme's EPS is $3.97 in '08, $4.73 in '09 and $5.55 in '10. Its price-to-earnings multiple works out to about 15 times '09 estimates.

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C+ What is this?

  • +
  • CVS
    Cvs Caremark Cp
  • $30.25
  • +1.95%
  • $29.86

He thinks CVS Caremark (CVS) is undervalued because it sells at 11 times 2009 EPS, versus an average of 15 times for pharmacy benefits-management plays generally. He notes that half the Woonsocket, R.I.-based company's earnings come from this benefits-management portion of the business, which can play an important role in controlling the country's drug costs. Return on invested capital is improving, and the company's business mix has been remarkably resilient over time, says Pesek. He began buying in the summer of 2007, when it was in the mid-30s. It has since dropped to below 25, but he sees good potential for growth, since it has about a 18% share of the prescriptions written in the U.S. That's below Walgreens' and mail-order's share but represents a rising portion compared to independent outlets. CVS' earnings are expected to be $2.46 a share in '08, $2.77 in '09 and $3.19 in '10.

People owning CVS also tend to own: ADMAVPBF-BBTICLDEOK

TheStreet.com Rating: B What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Jim Cramer's Portfolios of the Week

By Roberto Pedone According to Jim Cramer, investors shouldn’t read too much into Thursday’s market action. He reminded investors that the market has gone up for six...

11.13.09 | 12:48 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 12, 2009 According to CNBC’s “Fast Money” traders, stocks continued to move higher this week, maintaining their strength off the ...

11.12.09 | 11:44 AM
Squeezing the Shorts: Large-Cap ...

By Jonas Elmerraji Posted on Nov. 11, 2009 Recently we put our short-squeeze focus on smaller stocks; this week we’re going large-cap. With higher trading volumes, mo...

11.11.09 | 15:19 PM
Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...

11.10.09 | 15:04 PM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie J
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
more forums
today 's lists
Biggest % Losers

Here is the stock list of some of the largest % losers from Nov. 13, 2009. more

Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more

Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more